4102 Stock Overview
A bulk drug manufacturing company, supplies active pharmaceutical ingredients (APIs), API intermediates, and specialty chemicals worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Yung Zip Chemical Ind. Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$30.30 |
| 52 Week High | NT$41.85 |
| 52 Week Low | NT$29.35 |
| Beta | 0.0042 |
| 1 Month Change | -5.16% |
| 3 Month Change | -25.28% |
| 1 Year Change | -20.68% |
| 3 Year Change | 53.03% |
| 5 Year Change | 84.76% |
| Change since IPO | 203.00% |
Recent News & Updates
Recent updates
Yung Zip Chemical Ind (GTSM:4102) Seems To Use Debt Quite Sensibly
Apr 29
Yung Zip Chemical Ind. Co., Ltd.'s (GTSM:4102) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Mar 04Yung Zip Chemical Ind (GTSM:4102) Seems To Use Debt Quite Sensibly
Jan 28
Are Yung Zip Chemical Ind's (GTSM:4102) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 22Should Weakness in Yung Zip Chemical Ind. Co., Ltd.'s (GTSM:4102) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Nov 25Shareholder Returns
| 4102 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | -0.3% | 4.4% | 0.4% |
| 1Y | -20.7% | -0.2% | 28.7% |
Return vs Industry: 4102 underperformed the TW Pharmaceuticals industry which returned -0.2% over the past year.
Return vs Market: 4102 underperformed the TW Market which returned 28.7% over the past year.
Price Volatility
| 4102 volatility | |
|---|---|
| 4102 Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4102 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4102's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 184 | Ching Lin | www.yungzip.com |
Yung Zip Chemical Ind. Co., Ltd., a bulk drug manufacturing company, supplies active pharmaceutical ingredients (APIs), API intermediates, and specialty chemicals worldwide. It offers antihypertensive, iron chelator, anti-inflammatory, analgesic, antipyretic, anti-fungal, schizophrenia, anticoagulant, genital herpes outbreak, hypnotic, and sedative products. The company also offers excipients, such as sodium starch glycolate; and custom research and manufacturing services.
Yung Zip Chemical Ind. Co., Ltd. Fundamentals Summary
| 4102 fundamental statistics | |
|---|---|
| Market cap | NT$1.28b |
| Earnings (TTM) | NT$86.48m |
| Revenue (TTM) | NT$631.40m |
14.8x
P/E Ratio2.0x
P/S RatioIs 4102 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4102 income statement (TTM) | |
|---|---|
| Revenue | NT$631.40m |
| Cost of Revenue | NT$412.52m |
| Gross Profit | NT$218.88m |
| Other Expenses | NT$132.41m |
| Earnings | NT$86.48m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.04 |
| Gross Margin | 34.67% |
| Net Profit Margin | 13.70% |
| Debt/Equity Ratio | 15.2% |
How did 4102 perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield39%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 12:51 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yung Zip Chemical Ind. Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Regina Lee | IBTS Investment Consulting Co., Ltd. |
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| Yuan Lu | KGI Securities Co. Ltd. |